Lifecore Biomedical, Inc. (LFCR) shareholders
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.42+0.02 (+0.31%)
Close on Nov 13, 2026Market cap $243.02MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
67.1%
25M of 38M shares
Institutional holders
99
15 new, 19 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Kiper Christopher S Joint filing with Legion Partners Holdings, LLC (17.30%), White Raymond T. (17.30%) and 3 more | 6,991,919 | 17.30% | 13D (active) amendment | Sep 27, 2026 |
| Legion Partners Holdings, LLC Joint filing with Kiper Christopher S (17.10%), White Raymond T. (17.10%) and 3 more | 6,794,595 | 17.10% | 13D (active) amendment | Jun 30, 2026 |
| Nelson Obus Joint filing with Joshua Landes (13.90%), Wynnefield Capital Management, LLC (10.30%) and 1 more | 5,512,210 | 14.30% | 13D (active) amendment | Sep 27, 2026 |
| Aron R. English Joint filing with 22NW Fund, LP (11.10%), 22NW, LP (11.10%) and 2 more | 4,367,499 | 11.10% | 13D (active) amendment | Dec 23, 2024 |
| 22NW, LP Joint filing with 22NW Fund, LP (7.49%), 22NW Fund GP, LLC (7.49%) and 2 more | 2,975,398 | 7.49% | 13D (active) amendment | May 27, 2025 |
| 22NW GP, Inc. Joint filing with 22NW Fund, LP (6.74%), 22NW, LP (6.74%) and 2 more | 2,712,472 | 6.74% | 13D (active) amendment | Jun 30, 2026 |
| Greenhaven Road Investment Management, L.P. Joint filing with MVM Funds, LLC (7.80%), Scott Miller (7.80%) | 2,366,956 | 7.80% | 13G (passive) amendment | Dec 31, 2023 |
| BlackRock, Inc. | 2,010,546 | 5.40% | 13G (passive) | Jun 30, 2026 |
| Lw Capital Management, LLC | 1,578,197 | 5.20% | 13G (passive) | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LFCR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Wynnefield Capital Inc | 4,703,216 | 12.42% | $24.69M | – | 16.98% |
| Legion Partners Asset Management, LLC | 4,461,823 | 11.79% | $23.42M | – | 57.75% |
| Greenhaven Road Investment Management, L.P. | 3,190,769 | 8.43% | $16.75M | −346,804 | 10.88% |
| 325 Capital LLC | 2,895,881 | 7.65% | $15.20M | +733,415 | 3.62% |
| BlackRock, Inc. | 2,013,093 | 5.32% | $10.57M | +135,788 | 0.00% |
| Vanguard Capital Management LLC | 1,288,621 | 3.40% | $6.77M | −1,515 | 0.00% |
| Geode Capital Management, LLC | 855,500 | 2.26% | $4.49M | +40,393 | 0.00% |
| Morgan Stanley | 769,360 | 2.03% | $4.04M | +4,626 | 0.00% |
| State Street Corp | 668,031 | 1.76% | $3.51M | +26,025 | 0.00% |
| Quinn Opportunity Partners LLC | 453,495 | 1.20% | $2.38M | – | 0.11% |
| DCF Advisers, LLC | 424,500 | 1.12% | $2.23M | – | 0.39% |
| Wittenberg Investment Management, Inc. | 314,015 | 0.83% | $1.65M | +12,200 | 0.56% |
| Northern Trust Corp | 253,817 | 0.67% | $1.33M | +25,659 | 0.00% |
| Vanguard Fiduciary Trust Co | 239,924 | 0.63% | $1.26M | +2,859 | 0.00% |
| LPL Financial LLC | 207,300 | 0.55% | $1.09M | −490 | 0.00% |
| Vanguard Portfolio Management LLC | 189,073 | 0.50% | $992.63K | +24,513 | 0.00% |
| Marshall Wace, Llp | 177,471 | 0.47% | $931.72K | +119,117 | 0.00% |
| Tocqueville Asset Management L.P. | 151,700 | 0.40% | $796.43K | – | 0.01% |
| Millennium Management LLC | 133,305 | 0.35% | $699.85K | −23,852 | 0.00% |
| Goldman Sachs Group Inc | 124,940 | 0.33% | $655.94K | −43,436 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 99 | 25M | 67.1% | 15 / 35 | 22 / 19 | 2M | 2M |
| Q1 2026 | 105 | 25M | 66.3% | 20 / 30 | 33 / 18 | 3M | 1M |
| Q4 2025 | 104 | 25M | 65.5% | 19 / 33 | 27 / 14 | 1M | 1M |
| Q3 2025 | 100 | 24M | 64.3% | 20 / 28 | 29 / 6 | 1M | 1M |
| Q2 2025 | 86 | 25M | 65.4% | 16 / 34 | 18 / 17 | 2M | 2M |
| Q1 2025 | 87 | 25M | 64.8% | 16 / 29 | 19 / 4 | 1M | 1M |
| Q4 2024 | 76 | 25M | 65.5% | 13 / 28 | 20 / 19 | 5M | 1M |
| Q3 2024 | 82 | 21M | 54.7% | 19 / 33 | 12 / 11 | 3M | 1M |
| Q2 2024 | 75 | 20M | 53.8% | 19 / 23 | 20 / 23 | 2M | 5M |
| Q1 2024 | 79 | 23M | 61.2% | 16 / 24 | 19 / 15 | 2M | 1M |
| Q4 2023 | 78 | 22M | 58.1% | 19 / 17 | 19 / 10 | 3M | 4M |
| Q3 2023 | 69 | 22M | 58.2% | 8 / 17 | 19 / 14 | 4M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
92 funds held LFCR in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of LFCR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 822,113 | 2.17% | $4.32M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 729,481 | 1.93% | $3.83M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 435,402 | 1.15% | $2.29M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 302,667 | 0.80% | $1.34M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 240,314 | 0.63% | $1.26M | 0.01% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 198,393 | 0.52% | $995.93K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 142,471 | 0.38% | $715.20K | 0.00% | May 31, 2026 |
| Allspring Small Company Value Portfolio | 135,160 | 0.36% | $597.41K | 0.09% | Jul 31, 2026 |
| iShares Micro-Cap ETF | 94,903 | 0.25% | $498.24K | 0.03% | Jun 30, 2026 |
| 1290 VT GAMCO Small Company Value Portfolio | 78,000 | 0.21% | $409.50K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 69,936 | 0.18% | $351.08K | 0.00% | May 31, 2026 |
| Schwab Small-Cap Index Fund | 69,097 | 0.18% | $305.41K | 0.00% | Jul 31, 2026 |
| Ultra-Small Company Market Fund | 56,900 | 0.15% | $298.73K | 0.20% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 56,214 | 0.15% | $282.19K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 43,364 | 0.11% | $227.66K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul Josephs | Chief Executive Officer, Director | 592,915 | 1.57% | May 21, 2026 |
| Thomas D. Salus | Chief Legal & Administration | 246,333 | 0.65% | Apr 16, 2026 |
| Ryan David Lake | Chief Financial Officer | 336,691 | 0.89% | Sep 4, 2025 |
| Legion Partners, L.P. II | Director, 10% owner | 2,968,409 | 7.84% | Jun 8, 2026 |
| Raymond T. White | Director, 10% owner | – | – | Jun 8, 2026 |
| Legion Partners, L.P. I | Director, 10% owner | 4,507,236 | 11.91% | Jun 8, 2026 |
| Legion Partners Holdings, LLC | Director, 10% owner | 4,481,329 | 11.84% | Jun 8, 2026 |
| Legion Partners, LLC | Director, 10% owner | 2,940,340 | 7.77% | Jun 8, 2026 |
| Christopher S. Kiper | Director, 10% owner | 2,998,409 | 7.92% | Jun 8, 2026 |
| Legion Partners Asset Management, LLC | Director, 10% owner | 4,461,823 | 11.79% | Jun 8, 2026 |
| Lovas Katrina Houde | Director | 135,319 | 0.36% | Jun 5, 2026 |
| Nelson Obus | Director | 2,319,794 | 6.13% | Jun 5, 2026 |
| Joshua Schechter | Director | 135,080 | 0.36% | Jun 5, 2026 |
| Matthew E. Korenberg | Director | 69,967 | 0.18% | Jun 5, 2026 |
| Jason Aryeh | Director | 69,967 | 0.18% | Jun 5, 2026 |
| Paul Harold Johnson | Director | 69,967 | 0.18% | Jun 5, 2026 |
| Humberto Calheiros Antunes | Director | 72,967 | 0.19% | Jun 5, 2026 |
| 22nw, Lp | 10% owner | – | – | May 28, 2025 |
| Aron R. English | 10% owner | 264,180 | 0.70% | May 28, 2025 |
| 22NW Fund, LP | 10% owner | – | – | May 28, 2025 |
| 22NW Fund GP, LLC | 10% owner | 1,650,240 | 4.36% | May 28, 2025 |
| 22NW GP, Inc. | 10% owner | 1,714,070 | 4.53% | May 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Legion Partners, L.P. I Director, 10% owner | Jun 4, 2026 | Award | +25,907 | – | – | 103,482 |
| Matthew E. Korenberg Director | Jun 4, 2026 | Award | +25,907 | – | – | 69,967 |
| Lovas Katrina Houde Director | Jun 4, 2026 | Award | +25,907 | – | – | 135,319 |
| Paul Harold Johnson Director | Jun 4, 2026 | Award | +25,907 | – | – | 69,967 |
| Jason Aryeh Director | Jun 4, 2026 | Award | +25,907 | – | – | 69,967 |
| Nelson Obus Director | Jun 4, 2026 | Award | +25,907 | – | – | 164,100 |
| Joshua Schechter Director | Jun 4, 2026 | Award | +25,907 | – | – | 133,080 |
| Humberto Calheiros Antunes Director | Jun 4, 2026 | Award | +25,907 | – | – | 72,967 |
| Paul Josephs Chief Executive Officer, Director | May 20, 2026 | Tax withholding | −40,413 | $4.57 | $184.69K | 592,915 |
| Thomas D. Salus Chief Legal & Administration | Apr 14, 2026 | Tax withholding | −24,645 | $5.20 | $128.15K | 246,333 |
| Thomas D. Salus Chief Legal & Administration | Mar 2, 2026 | Award | +30,000 | – | – | 270,978 |
| Ryan David Lake Chief Financial Officer | Sep 3, 2025 | Tax withholding | −22,932 | $7.71 | $176.81K | 336,691 |
| Lovas Katrina Houde Director | Jul 15, 2025 | Award | +19,506 | – | – | 109,412 |
| Jason Aryeh Director | Jul 15, 2025 | Award | +19,506 | – | – | 44,060 |
| Humberto Calheiros Antunes Director | Jul 15, 2025 | Award | +19,506 | – | – | 47,060 |
| Paul Harold Johnson Director | Jul 15, 2025 | Award | +19,506 | – | – | 44,060 |
| Nelson Obus Director | Jul 15, 2025 | Award | +19,506 | – | – | 138,193 |
| Legion Partners Holdings, LLC Director, 10% owner | Jul 15, 2025 | Award | +19,506 | – | – | 77,575 |
| Joshua Schechter Director | Jul 15, 2025 | Award | +19,506 | – | – | 107,173 |
| Matthew E. Korenberg Director | Jul 15, 2025 | Award | +19,506 | – | – | 44,060 |
| Paul Josephs Chief Executive Officer, Director | Jul 8, 2025 | Tax withholding | −54,857 | $8.19 | $449.28K | 633,328 |
| Paul Josephs Chief Executive Officer, Director | Jul 8, 2025 | Option exercise | +150,000 | – | – | 688,185 |
| Ryan David Lake Chief Financial Officer | Jul 8, 2025 | Tax withholding | −32,806 | $8.19 | $268.68K | 359,623 |
| Ryan David Lake Chief Financial Officer | Jul 8, 2025 | Option exercise | +75,000 | – | – | 392,429 |
| Thomas D. Salus Chief Legal & Administration | Jul 8, 2025 | Tax withholding | −11,022 | $8.19 | $90.27K | 240,978 |
| Thomas D. Salus Chief Legal & Administration | Jul 8, 2025 | Option exercise | +37,000 | – | – | 252,000 |
| Aron R. English 10% owner | May 28, 2025 | Sale | −150,419 | $7.12 | $1.07M | 264,180 |
| Aron R. English 10% owner | May 27, 2025 | Sale | −1,139,504 | $6.50 | $7.41M | 414,599 |
| Aron R. English 10% owner | May 23, 2025 | Sale | −96,137 | $6.75 | $648.92K | 1,554,103 |
| Paul Josephs Chief Executive Officer, Director | May 20, 2025 | Tax withholding | −21,532 | $6.63 | $142.76K | 538,185 |
| 22NW Fund GP, LLC 10% owner | May 13, 2025 | Sale | −12,334 | $7.00 | $86.34K | 1,650,240 |
| 22NW Fund GP, LLC 10% owner | May 12, 2025 | Sale | −45,698 | $7.03 | $321.26K | 1,662,574 |
| 22NW Fund GP, LLC 10% owner | May 9, 2025 | Sale | −700 | $7.00 | $4.90K | 1,708,272 |
| 22NW Fund GP, LLC 10% owner | May 8, 2025 | Sale | −5,098 | $7.00 | $35.69K | 1,708,972 |
| 22NW GP, Inc. 10% owner | May 7, 2025 | Sale | −15,847 | $7.01 | $111.09K | 1,714,070 |
| 22NW GP, Inc. 10% owner | May 6, 2025 | Sale | −701 | $7.05 | $4.94K | 1,729,917 |
| 22NW GP, Inc. 10% owner | May 5, 2025 | Sale | −24,543 | $7.08 | $173.76K | 1,730,618 |
| Thomas D. Salus Chief Legal & Administration | Apr 14, 2025 | Award | +170,000 | – | – | 215,000 |
| Thomas D. Salus Chief Legal & Administration | Apr 14, 2025 | Award | +45,000 | – | – | 45,000 |
| Paul Josephs Chief Executive Officer, Director | Jan 8, 2025 | Buy | +17,000 | $5.74 | $97.58K | 559,717 |
| Ryan David Lake Chief Financial Officer | Dec 6, 2024 | Award | +19,720 | – | – | 323,082 |
| Ryan David Lake Chief Financial Officer | Dec 6, 2024 | Tax withholding | −5,653 | $7.15 | $40.42K | 317,429 |
| Paul Josephs Chief Executive Officer, Director | Dec 6, 2024 | Award | +38,461 | – | – | 554,486 |
| Paul Josephs Chief Executive Officer, Director | Dec 6, 2024 | Tax withholding | −11,769 | $7.15 | $84.15K | 542,717 |
| Ryan David Lake Chief Financial Officer | Oct 7, 2024 | Tax withholding | −34,138 | $5.09 | $173.76K | 303,362 |
| Ryan David Lake Chief Financial Officer | Oct 7, 2024 | Option exercise | +75,000 | – | – | 337,500 |
| Wynnefield Capital, Inc. Profit Sharing Plan 10% owner | Oct 3, 2024 | Buy | +122,930 | $4.10 | $504.01K | 2,095,783 |
| Wynnefield Capital, Inc. Profit Sharing Plan 10% owner | Oct 3, 2024 | Buy | +169,753 | $4.10 | $695.99K | 2,607,433 |
| Legion Partners Asset Management, LLC Director, 10% owner | Oct 3, 2024 | Buy | +1,311,312 | $4.10 | $5.38M | 4,084,268 |
| Legion Partners Asset Management, LLC Director, 10% owner | Oct 3, 2024 | Buy | +152,102 | $4.10 | $623.62K | 319,286 |
| Ryan David Lake Chief Financial Officer | Sep 3, 2024 | Award | +262,500 | – | – | 262,500 |
| Humberto Calheiros Antunes Director | Aug 19, 2024 | Award | +24,554 | – | – | 27,554 |
| Paul Harold Johnson Director | Aug 19, 2024 | Award | +24,554 | – | – | 24,554 |
| Humberto Calheiros Antunes Director | Aug 19, 2024 | Award | +24,554 | – | – | 24,554 |
| Jason Aryeh Director | Aug 19, 2024 | Award | +24,554 | – | – | 24,554 |
| Matthew E. Korenberg Director | Aug 19, 2024 | Award | +24,554 | – | – | 24,554 |
| Nelson Obus Director | Jul 8, 2024 | Award | +30,000 | – | – | 118,687 |
| Nathaniel Calloway Director | Jul 8, 2024 | Award | +30,000 | – | – | 58,069 |
| Christopher S. Kiper Director | Jul 8, 2024 | Award | +30,000 | – | – | 58,069 |
| Jeffrey L. Edwards Director | Jul 8, 2024 | Award | +30,000 | – | – | 79,667 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
8.44%
2M shares short
Days to cover
3.5
At 0M shares a day
Change since last report
-4.5%
From 2M shares
Short volume, 20 days
25.8%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lifecore Biomedical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 11,783 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John D. Morberg Former officer | Nov 20, 2024 | 10,000 | $71.69K | Nov 20, 2024 | Bonus |
| John D. Morberg Former officer | Nov 12, 2024 | 30,990 | $205.80K | Nov 11, 2024 | Bonus |
| John D. Morberg Former officer | Oct 31, 2024 | 40,989 | $232.89K | Oct 31, 2024 | Bonus |
| John D. Morberg Former officer | Oct 7, 2024 | 12,617 | $65.48K | Oct 7, 2024 | Open Market Purchase |
| John D. Morberg Former officer | Sep 20, 2024 | 15,000 | $82.35K | Sep 20, 2024 | Grants |
See a number that looks wrong?